Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Article in Periodical |
| Magazine / Source | LEUKEMIA & LYMPHOMA |
| MU Faculty or unit | |
| Citation | |
| web | https://www.tandfonline.com/doi/abs/10.1080/10428194.2022.2116931?journalCode=ilal20 |
| Doi | https://doi.org/10.1080/10428194.2022.2116931 |
| Keywords | RAS MUTATIONAMLGENE |
| Attached files | |
| Description | Oncogenic mutation in the NRAS are carried by 10-22% acute myeloid leukemia (AML) patients and represents one of the most commonly detected molecular aberrations in AML. |
| Related projects: |